UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Nature (London), 2017-05, Vol.545 (7655), p.446-451

2017

Link zum Volltext

Verfügbarkeit prüfen

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv192-iv237

2018

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

The New England journal of medicine, 2020-10, Vol.383 (18), p.1711-1723

2020

Link zum Volltext

Verfügbarkeit prüfen

A rectal cancer organoid platform to study individual responses to chemoradiation

Nature medicine, 2019-10, Vol.25 (10), p.1607-1614

2019

Link zum Volltext

Verfügbarkeit prüfen

Green tea (Camellia sinensis) for the prevention of cancer

Cochrane database of systematic reviews, 2020-03, Vol.3 (3), p.CD005004

2020

Link zum Volltext

Verfügbarkeit prüfen

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities

Cancer discovery, 2015-08, Vol.5 (8), p.860-877

2015

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

Cochrane database of systematic reviews, 2015-03, Vol.2015 (3), p.CD011430-CD011430

2015

Link zum Volltext

Verfügbarkeit prüfen

Asparagine bioavailability governs metastasis in a model of breast cancer

Nature (London), 2018-02, Vol.554 (7692), p.378-381

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2016-06, Vol.17 (6), p.822-835

2016

Link zum Volltext

Verfügbarkeit prüfen

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Nature (London), 2015-11, Vol.527 (7579), p.472-476

2015

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

The New England journal of medicine, 2019-11, Vol.381 (21), p.2020-2031

2019

Link zum Volltext

Verfügbarkeit prüfen

Shared heritability and functional enrichment across six solid cancers

Nature communications, 2019, Vol.10 (1), p.431-23, Article 431

2019

Link zum Volltext

Verfügbarkeit prüfen

Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

The New England journal of medicine, 2020-10, Vol.383 (14), p.1328-1339

2020

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer: current therapies and new targeted treatments

The Lancet (British edition), 2017-01, Vol.389 (10066), p.299-311

2017

Link zum Volltext

Verfügbarkeit prüfen

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Mayo Clinic proceedings, 2019-08, Vol.94 (8), p.1623-1640

2019

Link zum Volltext

Verfügbarkeit prüfen

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study

The lancet oncology, 2018-12, Vol.19 (12), p.1654-1667

2018

Link zum Volltext

Verfügbarkeit prüfen

Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study

Annals of oncology, 2018-11, Vol.29 (11), p.2214-2222

2018

Link zum Volltext

Verfügbarkeit prüfen

Visceral Disease in Castration-resistant Prostate Cancer

European urology, 2014-02, Vol.65 (2), p.270-273

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study

Cancer causes & control, 2009-05, Vol.20 (4), p.417-435

2009

Link zum Volltext

Verfügbarkeit prüfen

Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity

Nature medicine, 2019-09, Vol.25 (9), p.1428-1441

2019

Link zum Volltext

Verfügbarkeit prüfen

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Journal of clinical oncology, 2019-02, Vol.37 (4), p.278-285

2019

Link zum Volltext

Verfügbarkeit prüfen

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer

The Journal of clinical investigation, 2019-03, Vol.129 (3), p.1211-1228

2019

Link zum Volltext

Verfügbarkeit prüfen

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Nature communications, 2020-05, Vol.11 (1), p.2285-2285, Article 2285

2020

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 272.989

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225.877)
Mit Volltextzugriff
(193.919)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(231.352)
Japanisch
(41.670)
Chinesisch
(7.364)
Deutsch
(6.340)
Französisch
(6.095)
Russisch
(5.537)
Italienisch
(2.805)
Spanisch
(2.529)
Polnisch
(1.502)
Portugiesisch
(833)
Tschechisch
(491)
Niederländisch
(390)
Ungarisch
(387)
Dänisch
(358)
Rumänisch
(343)
Türkisch
(253)
Croatian
(245)
Norwegisch
(210)
Schwedisch
(186)
Serbian
(133)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(249.801)
Science & Technology
(191.076)
Life Sciences & Biomedicine
(182.123)
Male
(122.758)
Female
(120.020)
Middle Aged
(93.929)
Oncology
(82.985)
Lung Neoplasms - Pathology
(80.925)
Aged
(80.569)
Lung Cancer
(64.977)
Adult
(61.064)
Lung Neoplasms - Drug Therapy
(47.420)
Biological And Medical Sciences
(46.973)
Medical Sciences
(45.142)
Animals
(41.686)
Lung Neoplasms - Genetics
(36.509)
Tumors
(33.420)
Respiratory System
(30.388)
Lung Neoplasms - Surgery
(28.963)
Prognosis
(28.941)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(127.619)
IngentaConnect
(110.852)
RCN full-text journals@Ovid
(94.903)
IngentaConnect Journals
(52.017)
Single Journals
(51.257)
Elsevier ScienceDirect Journals Complete
(47.205)
Wiley Online Library - AutoHoldings Journals
(28.387)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(28.375)
SpringerLink (Online service)
(27.187)
Wiley Online Library
(17.534)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(16.800)
Oxford Journals Online Current
(9.264)
Nature Journals Online
(8.955)
Oxford Journals 2020 Medicine
(7.542)
JSTOR
(7.096)
Taylor & Francis
(6.070)
Taylor & Francis:Master (3349 titles)
(5.789)
British Medical Journals Online Archive (BMJ)
(5.612)
SAGE Journals
(5.291)
Nexis
(5.035)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(5.618)
Journal Of Thoracic Oncology
(4.290)
Cancer Research
(3.940)
Plos One
(3.912)
Cancer
(3.554)
Chest
(3.137)
The Annals Of Thoracic Surgery
(3.062)
International Journal Of Radiation Oncology, Biology, Physics
(2.575)
Zhongguo Fei Ai Za Zhi
(2.387)
Journal Of Clinical Oncology
(2.386)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

A rectal cancer organoid platform to study individual responses to chemoradiation

Green tea (Camellia sinensis) for the prevention of cancer

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

Asparagine bioavailability governs metastasis in a model of breast cancer

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

Shared heritability and functional enrichment across six solid cancers

Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

Lung cancer: current therapies and new targeted treatments

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study

Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study

Visceral Disease in Castration-resistant Prostate Cancer

Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study

Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Suchergebnisse filtern